|
1
|
Bednarek AK, Laflin KJ, Daniel RL, Liao Q,
Hawkins KA and Aldaz CM: WWOX, a novel WW domain-containing protein
mapping to human chromosome 16q23.3–24.1, a region frequently
affected in breast cancer. Cancer Res. 60:2140–2145.
2000.PubMed/NCBI
|
|
2
|
Iliopoulos D, Guler G, Han SY, Johnston D,
Druck T, McCorkell KA, Palazzo J, McCue PA, Baffa R and Huebner K:
Fragile genes as biomarkers: Epigenetic control of WWOX and FHIT in
lung, breast and bladder cancer. Oncogene. 24:1625–1633. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Lan C, Chenggang W, Yulan B, Xiaohui D,
Junhui Z and Xiao W: Aberrant expression of WWOX protein in
epithelial ovarian cancer: A clinicopathologic and
immunohistochemical study. Int J Gynecol Pathol. 31:125–132. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Ekizoglu S, Muslumanoglu M, Dalay N and
Buyru N: Genetic alterations of the WWOX gene in breast cancer. Med
Oncol. 29:1529–1535. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Guo W, Wang G, Dong Y, Guo Y, Kuang G and
Dong Z: Decreased expression of WWOX in the development of
esophageal squamous cell carcinoma. Mol Carcinog. 52:265–274. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Hu BS, Tan JW, Zhu GH, Wang DF, Zhou X and
Sun ZQ: WWOX induces apoptosis and inhibits proliferation of human
hepatoma cell line SMMC-7721. World J Gastroenterol. 18:3020–3026.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Nakayama S, Semba S, Maeda N, Matsushita
M, Kuroda Y and Yokozaki H: Hypermethylation-mediated reduction of
WWOX expression in intraductal papillary mucinous neoplasms of the
pancreas. Br J Cancer. 100:1438–1443. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Huang C, Tian Y, Peng R, et al:
Down-regulation of WWOX is associated with poor prognosis in
patients with intrahepatic cholangiocarcinoma after Curative
Resection. J Gastroenterol Hepatol. 30:421–433. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Göthlin Eremo A, Wegman P, Stål O,
Nordenskjöld B, Fornander T and Wingren S: Wwox expression may
predict benefit from adjuvant tamoxifen in randomized breast cancer
patients. Oncol Rep. 29:1467–1474. 2013.PubMed/NCBI
|
|
10
|
Cancemi L, Romei C, Bertocchi S, Tarrini
G, Spitaleri I, Cipollini M, Landi D, Garritano S, Pellegrini G,
Cristaudo A, et al: Evidences that the polymorphism Pro-282-Ala
within the tumor suppressor gene WWOX is a new risk factor for
differentiated thyroid carcinoma. Int J Cancer. 129:2816–2824.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Ishii H, Vecchione A, Furukawa Y,
Sutheesophon K, Han SY, Druck T, Kuroki T, Trapasso F, Nishimura M,
Saito Y, et al: Expression of FRA16D/WWOX and FRA3B/FHIT genes in
hematopoietic malignancies. Mol Cancer Res. 1:940–947.
2003.PubMed/NCBI
|
|
12
|
Ishii H and Furukawa Y: Alterations of
common chromosome fragile sites in hematopoietic malignancies. Int
J Hematol. 79:238–242. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Chen X, Zhang H, Li P, Yang Z, Qin L and
Mo W: Gene expression of WWOX, FHIT and p73 in acute lymphoblastic
leukemia. Oncol Lett. 6:963–969. 2013.PubMed/NCBI
|
|
14
|
Cui Z, Lin D, Cheng F, Luo L, Kong L, Xu
J, Hu J and Lan F: The role of the WWOX gene in leukemia and its
mechanisms of action. Oncol Rep. 29:2154–2162. 2013.PubMed/NCBI
|
|
15
|
Lin D, Cui Z, Kong L, Cheng F, Xu J and
Lan F: p73 participates in WWOX-mediated apoptosis in leukemia
cells. Int J Mol Med. 31:849–854. 2013.PubMed/NCBI
|
|
16
|
Zhang H, Kong L, Cui Z, Du W, He Y, Yang
Z, Wang L and Chen X: The WWOX gene inhibits the growth of U266
multiple myeloma cells by triggering the intrinsic apoptotic
pathway. Int J Mol Med. 34:804–809. 2014.PubMed/NCBI
|
|
17
|
Bennett JM, Catovsky D, Daniel MT,
Flandrin G, Galton DA, Gralnick HR and Sultan C: Proposals for the
classification of the acute leukaemias. French-American-British
(FAB) co-operative group. Br J Haematol. 33:451–458. 1976.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Chen J, Odenike O and Rowley JD:
Leukaemogenesis: More than mutant genes. Nat Rev Cancer. 10:23–36.
2010. View
Article : Google Scholar : PubMed/NCBI
|
|
19
|
Aqeilan RI and Croce CM: WWOX in
biological control and tumorigenesis. J Cell Physiol. 212:307–310.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Gardenswartz A and Aqeilan RI: WW
domain-containing oxidoreductase's role in myriad cancers: Clinical
significance and future implications. Exp Biol Med (Maywood).
239:253–263. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Guo W, Dong Z, Dong Y, Guo Y, Kuang G and
Yang Z: Genetic and epigenetic alterations of WWOX in the
development of gastric cardia adenocarcinoma. Environ Mol Mutagen.
54:112–123. 2013. View
Article : Google Scholar : PubMed/NCBI
|
|
22
|
Guler G, Uner A, Guler N, Han SY,
Iliopoulos D, McCue P and Huebner K: Concordant loss of fragile
gene expression early in breast cancer development. Pathol Int.
55:471–478. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Diniz MG, Borges ER, Pimenta FJ, De
Mesquita Netto AC, De Marco L, Gomez RS and Gomes CC: Evidence of
molecular alterations in the tumour suppressor gene WWOX in benign
and malignant bone related lesions of the jaws. Oncol Rep.
25:499–502. 2011.PubMed/NCBI
|
|
24
|
Maeda N, Semba S, Nakayama S, Yanagihara K
and Yokozaki H: Loss of WW domain-containing oxidoreductase
expression in the progression and development of gastric carcinoma:
Clinical and histopathologic correlations. Virchows Arch.
457:423–432. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Chen X, Li P, Yang Z and Mo WN: Expression
of fragile histidine triad (FHIT) and WW-domain oxidoreductase gene
(WWOX) in nasopharyngeal carcinoma. Asian Pac J Cancer Prev.
14:165–171. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Donati V, Fontanini G, Dell'Omodarme M,
Prati MC, Nuti S, Lucchi M, Mussi A, Fabbri M, Basolo F, Croce CM
and Aqeilan RI: WWOX expression in different histologic types and
subtypes of non-small cell lung cancer. Clin Cancer Res.
13:884–891. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Nunez MI, Rosen DG, Ludes-Meyers JH, Abba
MC, Kil H, Page R, Klein-Szanto AJ, Godwin AK, Liu J, Mills GB and
Aldaz CM: WWOX protein expression varies among ovarian carcinoma
histotypes and correlates with less favorable outcome. BMC Cancer.
5:642005. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Yan H, Yu N and Tong J: Effects of
5-Aza-2′-deoxycytidine on the methylation state and function of the
WWOX gene in the HO-8910 ovarian cancer cell line. Oncol Lett.
6:845–849. 2013.PubMed/NCBI
|
|
29
|
Göthlin Eremo A, Wegman P, Stål O,
Nordenskjöld B, Fornander T and Wingren S: Wwox expression may
predict benefit from adjuvant tamoxifen in randomized breast cancer
patients. Oncol Rep. 29:1467–1474. 2013.PubMed/NCBI
|
|
30
|
Guler G, Iliopoulos D, Guler N, Himmetoglu
C, Hayran M and Huebner K: Wwox and Ap2gamma expression levels
predict tamoxifen response. Clin Cancer Res. 13:6115–6121.. 2007.
View Article : Google Scholar : PubMed/NCBI
|
